PubMed:29955381
Annnotations
Zierdiyeerkenaili_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 508-510 | DP | denotes | RA |
| T10 | 435-445 | CI | denotes | adalimumab |
| T11 | 558-568 | CI | denotes | adalimumab |
| T12 | 755-765 | CI | denotes | adalimumab |
| T13 | 982-992 | CI | denotes | adalimumab |
| T14 | 1045-1055 | CI | denotes | adalimumab |
| T15 | 1314-1324 | CI | denotes | adalimumab |
| T16 | 1356-1366 | CI | denotes | adalimumab |
| T17 | 2055-2065 | CI | denotes | adalimumab |
| T18 | 542-554 | CI | denotes | methotrexate |
| T19 | 105-117 | CI | denotes | methotrexate |
| T2 | 315-317 | DP | denotes | RA |
| T20 | 366-378 | CI | denotes | methotrexate |
| T21 | 446-458 | CI | denotes | methotrexate |
| T22 | 570-582 | CI | denotes | methotrexate |
| T23 | 830-842 | CI | denotes | methotrexate |
| T24 | 1071-1083 | CI | denotes | methotrexate |
| T25 | 1373-1385 | CI | denotes | methotrexate |
| T26 | 1420-1432 | CI | denotes | methotrexate |
| T27 | 1434-1446 | CI | denotes | methotrexate |
| T28 | 1501-1513 | CI | denotes | methotrexate |
| T29 | 1550-1562 | CI | denotes | methotrexate |
| T3 | 293-313 | DP | denotes | rheumatoid arthritis |
| T30 | 1822-1834 | CI | denotes | methotrexate |
| T31 | 1874-1884 | CI | denotes | Adalimumab |
| T32 | 2066-2086 | CI | denotes | methotrexate therapy |
| T4 | 135-155 | DP | denotes | rheumatoid arthritis |
| T5 | 530-540 | CI | denotes | adalimumab |
| T6 | 17-27 | CI | denotes | adalimumab |
| T7 | 89-99 | CI | denotes | adalimumab |
| T8 | 329-339 | CI | denotes | adalimumab |
| T9 | 355-365 | CI | denotes | adalimumab |
| T34 | 469-481 | CI | denotes | Methotrexate |
| T35 | 993-1009 | CI | denotes | methotrexate who |
yaoziqian_800_3
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T1 | 135-155 | DP | denotes | rheumatoid arthritis |
| T10 | 469-481 | CI | denotes | Methotrexate |
| T11 | 508-510 | DP | denotes | RA |
| T12 | 530-540 | CI | denotes | adalimumab |
| T13 | 542-554 | CI | denotes | methotrexate |
| T14 | 558-568 | CI | denotes | adalimumab |
| T15 | 570-582 | CI | denotes | methotrexate |
| T16 | 755-765 | CI | denotes | adalimumab |
| T17 | 982-992 | CI | denotes | adalimumab |
| T19 | 1045-1055 | CI | denotes | adalimumab |
| T2 | 89-99 | CI | denotes | adalimumab |
| T20 | 1071-1083 | CI | denotes | methotrexate |
| T21 | 17-27 | CI | denotes | adalimumab |
| T23 | 1314-1324 | CI | denotes | adalimumab |
| T24 | 1356-1366 | CI | denotes | adalimumab |
| T25 | 1420-1432 | CI | denotes | methotrexate |
| T26 | 1434-1446 | CI | denotes | methotrexate |
| T27 | 1373-1385 | CI | denotes | methotrexate |
| T28 | 1501-1513 | CI | denotes | methotrexate |
| T29 | 1550-1562 | CI | denotes | methotrexate |
| T3 | 105-117 | CI | denotes | methotrexate |
| T30 | 1822-1834 | CI | denotes | methotrexate |
| T31 | 1874-1884 | CI | denotes | Adalimumab |
| T32 | 2055-2065 | CI | denotes | adalimumab |
| T33 | 2066-2086 | CI | denotes | methotrexate therapy |
| T4 | 293-313 | DP | denotes | rheumatoid arthritis |
| T5 | 329-339 | CI | denotes | adalimumab |
| T6 | 355-365 | CI | denotes | adalimumab |
| T7 | 366-378 | CI | denotes | methotrexate |
| T8 | 435-445 | CI | denotes | adalimumab |
| T9 | 446-458 | CI | denotes | methotrexate |
| T34 | 315-317 | DP | denotes | RA |
| T35 | 993-1009 | CI | denotes | methotrexate who |
| T36 | 830-842 | CI | denotes | methotrexate |